Dengue is a vector-borne viral illness whose manifestations vary from asymptomatic illness to life-threatening forms such as dengue hemorrhagic fever (DHF) and dengue shock syndrome. It is an endemic disease in many parts of India with frequent epidemic episodes causing significant morbidity and mortality. Thrombocytopenia is a hallmark of dengue1 and may require platelet transfusion in cases with bleeding. Often, platelets are transfused prophylactically in an attempt to prevent hemorrhagic complications. Here, we report three patients presenting to us with development of panophthalmitis and endophthalmitis immediately after receiving platelet transfusion.
The American Society of Tropical Medicine and Hygiene (ASTMH) assisted with publication expenses.
Lee T-H, Wong JGX, Leo Y-S, Thein T-L, Ng E-L, Lee LK, Lye DC, 2016. Potential harm of prophylactic platelet transfusion in adult dengue patients. PLoS Negl Trop Dis 10: e0004576.
Centers for Disease Control and Prevention, 2004. Fatal Bacterial Infections Associated with Platelet Transfusions—United States. Available at: https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5407a2.htm. Accessed October 22, 2017.
Tan N, Galvante PRE, Chee SP, 2014. Endogenous Serratia marcescens endophthalmitis: an atypical presentation. Eye (Lond) 28: 108–109.
Vivekanand U, Pakalapati P, Reddy GS, Talluri S, 2014. Methicillin resistant Staphylococcus epidermidis induced endogenous endophthalmitis. J Clin Diagn Res 8: VD01–VD02.